Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study testing one-day accelerated transcranial magnetic stimulation (TMS) with D-cycloserine in suicidal patients with Borderline Personality …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: Mclean Hospital | Conditions: Borderline Personality Disorder (BPD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING